Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer.
Fiche publication
Date publication
janvier 2024
Journal
Current oncology reports
Auteurs
Membres identifiés du Cancéropôle Est :
Dr STREIT Arthur
Tous les auteurs :
Streit A, Lampridis S, Seitlinger J, Renaud S, Routledge T, Bille A
Lien Pubmed
Résumé
With increased detection of early-stage non-small cell lung cancer (NSCLC) owing to screening, determining optimal management increasingly hinges on assessing resectability and operability. Resectability refers to the feasibility of achieving microscopically negative margins based on tumour size, location and degree of local invasion and achieving an anatomical lobar resection. Operability reflects the patient's tolerance for resection based on comorbidities, cardiopulmonary reserve and frailty. Standardized criteria help guide these assessments, but application variability contributes to practice inconsistencies. This review synthesizes a strategic approach to evaluating resectability and operability in contemporary practice. Standardization promises reduced care variability and optimized patient selection to maximize curative outcomes in this new era of early detection.
Mots clés
Early-stage non-small cell lung cancer, Lung segmentectomy, Non-small cell lung cancer surgery
Référence
Curr Oncol Rep. 2024 01;26(1):55-64